{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:36:40Z","timestamp":1755794200006,"version":"3.44.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"DOI":"10.7759\/cureus.90154","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T14:46:47Z","timestamp":1755269207000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Therapeutic Challenges in Aggressive Diffuse Large B-Cell Lymphoma of Immune-Privileged Sites: A Case Report of Orbital and Cervical Involvement in an End-Stage Renal Disease (ESRD) Patient"],"prefix":"10.7759","author":[{"given":"Ravada  R","family":"Hemanth Sai Sri Harsha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahima","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manidipa","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-018-0555-8","article-title":"Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence","volume":"19","author":"Ollila TA","year":"2018","unstructured":"Ollila TA, Olszewski AJ. Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence. Curr Treat Options Oncol. 2018, 19:38. 10.1007\/s11864-018-0555-8","journal-title":"Curr Treat Options Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn LH","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021, 384:842-58. 10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12236","article-title":"Diffuse large B-cell lymphoma in immunoprivileged sites: association of vitreoretinal, testicular and central nervous system lymphoma","volume":"92","author":"Riemens A","year":"2014","unstructured":"Riemens A, Missotten T, Baarsma S, et al.. Diffuse large B-cell lymphoma in immunoprivileged sites: association of vitreoretinal, testicular and central nervous system lymphoma. Acta Ophthalmol. 2014, 92:e159-60. 10.1111\/aos.12236","journal-title":"Acta Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13223424","article-title":"CNS involvement of DLBCL presenting with an unusual non-enhancing infiltrative mass","volume":"13","author":"Hsueh FS","year":"2023","unstructured":"Hsueh FS, Chen HC, Tzeng HE. CNS involvement of DLBCL presenting with an unusual non-enhancing infiltrative mass. Diagnostics (Basel). 2023, 13:3424. 10.3390\/diagnostics13223424","journal-title":"Diagnostics (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(91)90002-w","article-title":"Secondary optic nerve tumors","volume":"36","author":"Christmas NJ","year":"1991","unstructured":"Christmas NJ, Mead MD, Richardson EP, et al.. Secondary optic nerve tumors. Surv Ophthalmol. 1991, 36:196-206. 10.1016\/0039-6257(91)90002-w","journal-title":"Surv Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1974.01010010286003","article-title":"Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases","volume":"92","author":"Ferry AP","year":"1974","unstructured":"Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Arch Ophthalmol. 1974, 92:276-86. 10.1001\/archopht.1974.01010010286003","journal-title":"Arch Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007268","article-title":"Treatment outcome of diffuse large B-cell lymphoma involving the head and neck: two-institutional study for the significance of radiotherapy after R-CHOP chemotherapy","volume":"96","author":"Kwak YK","year":"2017","unstructured":"Kwak YK, Choi BO, Kim SH, Lee JH, Kang DG, Lee JH. Treatment outcome of diffuse large B-cell lymphoma involving the head and neck: two-institutional study for the significance of radiotherapy after R-CHOP chemotherapy. Medicine (Baltimore). 2017, 96:e7268. 10.1097\/MD.0000000000007268","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030835","article-title":"The Immunology of DLBCL","volume":"15","author":"Takahara T","year":"2023","unstructured":"Takahara T, Nakamura S, Tsuzuki T, Satou A. The Immunology of DLBCL. Cancers (Basel). 2023, 15:835. 10.3390\/cancers15030835","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large B-cell lymphoma","volume":"87","author":"Martelli M","year":"2013","unstructured":"Martelli M, Ferreri AJ, Agostinelli C, Di Rocco A, Pfreundschuh M, Pileri SA. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol. 2013, 87:146-71. 10.1016\/j.critrevonc.2012.12.009","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright GW","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD, et al.. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020, 37:551-68.e14. 10.1016\/j.ccell.2020.03.015","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz R","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, et al.. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018, 378:1396-407. 10.1056\/NEJMoa1801445","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31646","article-title":"Double hit and double expressors in lymphoma: definition and treatment","volume":"124","author":"Riedell PA","year":"2018","unstructured":"Riedell PA, Smith SM. Double hit and double expressors in lymphoma: definition and treatment. Cancer. 2018, 124:4622-32. 10.1002\/cncr.31646","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S326632","article-title":"Diffuse large B-cell lymphoma (DLBCL): early patient management and emerging treatment options","volume":"15","author":"Vodicka P","year":"2022","unstructured":"Vodicka P, Klener P, Trneny M. Diffuse large B-cell lymphoma (DLBCL): early patient management and emerging treatment options. Onco Targets Ther. 2022, 15:1481-501. 10.2147\/OTT.S326632","journal-title":"Onco Targets Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy B","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, et al.. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018, 24:679-90. 10.1038\/s41591-018-0016-8","journal-title":"Nat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/370799-clinical-and-therapeutic-challenges-in-aggressive-diffuse-large-b-cell-lymphoma-of-immune-privileged-sites-a-case-report-of-orbital-and-cervical-involvement-in-an-end-stage-renal-disease-esrd-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T14:46:48Z","timestamp":1755269208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/370799-clinical-and-therapeutic-challenges-in-aggressive-diffuse-large-b-cell-lymphoma-of-immune-privileged-sites-a-case-report-of-orbital-and-cervical-involvement-in-an-end-stage-renal-disease-esrd-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.90154","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]}}}